170681 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Hydrolases (3) acting on peptide bonds (3.4) Trypsin; Chymotrypsin
SIZE-BASED HIERARCHICAL EXTRACTION AND IDENTIFICATION METHOD FOR MICROPLASTICS IN BIVALVES FROM DEEP-SEA METHANE SEEPS
#2METHODS FOR THE TREATMENT OF SYMPTOMS OF NEUROLOGICAL AND MENTAL HEALTH DISORDERS
#3ENZYME-IMMOBLIZED PARTICLES FOR ONLINE PROTEIN DIGESTION
#4PARTICLE COUNTING AND BIOMASS MEASUREMENTS OF AGGREGATED CELL COMPOSITIONS
#5COMPOSITION COMPRISING AFLIBERCEPT AND A VARIANT THEREOF, AND RELATED METHODS AND USES
#6METHODS FOR DETECTING METABOLIC MARKERS
#7SYNTHESIS OF SELF-ASSEMBLING ARTIFICIAL PROTEINS UTILIZING A HOST-GUEST SYSTEM AND USES THEREOF
#8p53 FRAGMENTS AS MARKERS FOR DIAGNOSIS AND PROGNOSIS OF NEURODEGENERATIVE DISEASE STATES
#9TARGETED MASS SPECTROMETRY METHODOLOGY FOR DETECTING KLOTHO ISOFORMS
#10COMBINATORIAL HIGH-THROUGHPUT SCREENING OF COMPLEX POLYMERIC ENZYME IMMOBILIZATION SUPPORTS
#11AFUCOSYLATION OF HLA-SPECIFIC IGG1 AS A POTENTIAL PREDICTOR OF ANTIBODY PATHOGENICITY IN KIDNEY TRANSPLANTATION
#12GLYCAN STRUCTURES OF HAPTOGLOBIN AS A BIOMARKER OF HEPATOCELLULAR CARCINOMA
#13METHODS OF TRACKING DONOR CELLS IN A RECIPIENT
#14COMPOSITION FOR DIAGNOSING CANCER
#15METHODS FOR CHARACTERIZING A PROTEIN OF INTEREST
#16METHOD FOR DETERMINING THE METHICILLIN RESISTANCE OF STAPHYLOCOCCUS AUREUS STRAINS
#17METHOD AND TOOLS FOR THE DETERMINATION OF CONFORMATIONS AND CONFORMATIONAL CHANGES OF PROTEINS AND OF DERIVATIVES THEREOF
#18HOST CELL PROTEIN ANALYSIS FOR ADENO-ASSOCIATED VIRUS (AAV)-BASED GENE THERAPY
#19METHOD FOR DETECTION AND QUANTIFICATION OF IMMUNOGLOBULIN FREE LIGHT CHAIN DIMERS
#20METHOD FOR DETECTING PROTEIN HAVING CHANGES IN ENERGY STATE, OR AFFINITY OF LIGAND TO PROTEIN
#21METHODS FOR THE MEASUREMENT OF PROTEIN C AND ACTIVATED PROTEIN C
#22Biopharmaceutical Compositions and Stable Isotope Labeling Peptide Mapping Method
#23CANCER RISK ASSESSMENT
#24CHARACTERIZATION OF SERINE-LYSINE CROSS-LINK IN ANTIBODY HIGH MOLECULAR WEIGHT SPECIES
#25PROTEOMIC SAMPLE INVESTIGATION METHOD FOR DIAGNOSING RHABDOMYOLYSIS AND KITS FOR IMPLEMENTING SAME
#26Compositions For and Methods of Evaluating Gap Junction Formation and Function
#27P53 POST-TRANSLATIONAL MODIFICATIONS AS MARKERS IN THE DIAGNOSIS AND PROGNOSIS OF A NEURODEGENERATIVE DISEASE
#28PROTEIN MARKERS FOR THE PROGNOSIS OF BREAST CANCER PROGRESSION
#29PEPTIDE DECORATED NANOPARTICLES FOR ENRICHMENT OF SPECIFIC PROTEIN SUBSETS
#30COMPOUNDS COMPRISING AN ISOBARIC REGION, AN ENRICHMENT HANDLE, AND A THIOL-REACTIVE GROUP, AND METHODS OF USING THE SAME
#31Miniaturized Proteomic Sample Preparation
#32BIOLOGICAL SAMPLE PREPARATION AND ANALYSIS
#33METHODS OF PROCESSING A SAMPLE FOR PEPTIDE MAPPING ANALYSIS
#34Systems and Methods for Assaying Large Molecules with Improved Sensitivity
#35TRYPSIN DETECTION FILM, PREPARATION METHOD THEREFOR, APPLICATION THEREOF, AND TRYPSIN DETECTION KIT
#36HYDROPHOBICITY SHIFTED ENZYME
#37COMPOSITIONS AND METHODS FOR DIAGNOSING, PREVENTING, AND TREATING AMYOTROPHIC LATERAL SCLEROSIS IN PATIENTS WITH HYPOFUNCTIONAL ANTI-TRYPSIN ACTIVITY
#38p53 POST-TRANSLATIONAL MODIFICATIONS AS MARKERS IN THE DIAGNOSIS AND PROGNOSIS OF A NEURODEGENERATIVE DISEASE
#39Method for evaluating metabolizable energy in goose diet by using a simulative digestion gross energy technique
#40BETA-CASEIN ANALYSIS OF MILK AND MILK PRODUCTS
#41METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF NEUROLOGICAL AND MENTAL HEALTH DISORDERS
#42Method for preparing peptide fragments, kit for preparing peptide fragments to be used therein, and analysis method
#43Quantitative analysis of proteins
#44Method for quantifying monoclonal antibody having antigen or anti-antibody bonded thereto
#45Method for preparing peptide fragments, kit for preparing peptide fragments to be used therein, and analysis method
#46PROTEOLYTIC DIGESTION OF CARDIAC TROPONIN I
#47Method for Treating Pervasive Development Disorders
#48Methods and compositions for the treatment of symptoms of prion diseases
#49Assay devices and methods
#50Proteolytic digestion of cardiac troponin I
#51Method of detecting at least one mechanism of resistance to carbapenems by mass spectrometry
#52SRM/MRM assay for the mesothelin (MSLN) protein
#53Mass spectrometric assays for peptides
#54Method for preparing peptide fragments, kit for preparing peptide fragments to be used therein, and analysis method
#55SOLID PHASE EXTRACTION OF GLOBAL PEPTIDES, GLYCOPEPTIDES, AND GLYCANS USING CHEMICAL IMMOBILIZATION IN A PIPETTE TIP
#56Methods and compositions for the treatment of symptoms of Williams Syndrome
#57RATIOMETRIC ASSAY FOR HYDROLYTIC ENZYME QUANTIFICATION
#58Method for the analysis of N-glycans attached to immunoglobulin G from human blood plasma and its use
#59CHARACTERIZATION OF THERMOSTABLE DNA POLYMERASE
#60System and method for the detection of allergens
#61High-molecular-weight adiponectin measurement method
#62Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
#63ANALYSIS OF DISULFIDE BONDS
#64Methods and compositions for the treatment of symptoms of prion diseases
#65QUANTIFICATION OF TAU IN BIOLOGICAL SAMPLES BY IMMUNOAFFINITY ENRICHMENT AND MASS SPECTROMETRY
#66Method of detecting at least one mechanism of resistance to carbapenems by mass spectrometry
#67Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity
#68Screening for protein variants using mass spectrometry
#69Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
#70Methods and compositions for the treatment of symptoms of prion diseases
#71Mass spectrometric assays for peptides
#72COMPOSITIONS AND METHODS FOR MONITORING BREAST CANCER TREATMENT
#73HIGH-MOLECULAR-WEIGHT ADIPONECTIN MEASUREMENT METHOD
#74Method for treating pervasive development disorders
#75Method for treating pervasive development disorders
#76Compositions comprising enzyme-cleavable oxycodone prodrug
#77Method for treating pervasive development disorders
#78Method for treating pervasive development disorders
#79Methods for early detection of blood disorders
#80COMPOSITIONS COMPRISING ENZYME-CLEAVABLE OPIOID PRODRUGS AND INHIBITORS THEREOF
#81Nucleic acid ligand complexes
#82Methods and compositions for the treatment of symptoms of neurological and mental health disorders
#83Device And Use Thereof
#84UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR CANCER DIAGNOSIS
#85UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR PROLIFERATIVE HEMATOLOGICAL DISORDERS
#86UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR CANCER DIAGNOSIS
#87HIGH-MOLECULAR-WEIGHT ADIPONECTIN MEASUREMENT METHOD
#88Cascade enzyme-linked immunosorbent assay
#89PREDICTIVE DIAGNOSTICS FOR KIDNEY DISEASE
#90BIOMOLECULES
#91Compositions and methods for monitoring breast cancer treatment
#92METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF PRION DISEASES
#93Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity
#94Methods and compositions for the treatment of symptoms of Williams Syndrome
#95Mass spectrometric determination of blood enzyme activity
#96Method for identifying individuals having a pervasive development disorder amenable to digestive enzyme therapy
#97Distinguishing cells in a sample by inactivating extracellular enzyme before releasing intracellular enzyme
#98COMPOUNDS FOR ENZYME INHIBITION
#99Method for identifying autistic individuals amenable to digestive enzyme therapy
#100Method for determining inhibitors of neurotrypsin
#101Method for treating pervasive development disorders
#102Methods for the early diagnosis of ovarian cancer
#103Monoclonal antibodies for detection of urinary trypsin inhibitors
#104Screening method for protein variants using mass spectrometry
#105Immunotherapeutic methods targeted toward stratum corneum chymotryptic enzyme
#106Process for the preparation of "Urchym" a urease and alpha-chymotrypsin enzyme inhibitory drug
#107Methods of treating pervasive development disorders
#108PROTEASOMAL PEPTIDASE ACTIVITY AND THE USE THEREOF IN CLINICAL APPLICATIONS
#109Biomarker isolation and use thereof to characterize physiological state
#110Compositions and methods for monitoring breast cancer treatment
#111Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
#112Monoclonal antibodies for detection of urinary trypsin inhibitors
#113Methods and kits useful for the simplification of complex peptide mixtures
#114Methods for treating pervasive development disorders
#115Methods for treating pervasive development disorders
#116Tenascin-C nucleic acid ligands
#117Systematic evolution of ligands by exponential enrichment: Chemi-SELEX
#118Compounds for enzyme inhibition
#119Detecting cell membrane protein endocytosis
#120Novel bicyclic hydroxamates as inhibitors of histone deacetylase
#121Nucleic acid ligand complexes
#122Truncation SELEX method
#123High affinity RNA ligands of basic fibroblast growth factor
#124Compositions and methods for monitoring breast cancer treatment
#125Composition comprising aflibercept and a variant thereof, and related methods and uses